PEACCEL
  • Home
  • About
    • PEACCEL at a glance
    • Management
    • Scientific Team
    • Publications
  • Technology
    • innov’SAR Platform
    • Computational Resources
  • Services
    • How PEACCEL Can Support You
    • Examples
  • News
  • Contact
  • PEACCEL
  • News
  • PRAXISforum Enzymes for Industrial Applications 2020, 4-5 February 2020, Frankfurt, Germany
Feb 03 0

PRAXISforum Enzymes for Industrial Applications 2020, 4-5 February 2020, Frankfurt, Germany

Posted by Webmaster

Meet PEACCEL at PRAXISforum Enzymes for Industrial Applications 2020.

Rudy PANDJAITAN (Chief Business Officer) will be representing PEACCEL at this event.

  News  

Recent News

  • The CEO of PEACCEL, Laurent Contaut, has been awarded “CEO of the Year 2021” by AI Global Media Ltd
  • PEACCEL mentioned as a AI start-up to watch by NVIDIA
  • PEACCEL listed in the Global AI-based Drug Discovery Market Report 2021:  Market report by Cision (NYSE: CISN).
  • PEACCEL awarded by Wealth & Finance
  • PEACCEL awarded by CIO Review

Categories

  • News
  • Paper Highlights
  • Press Release

About PEACCEL

PEACCEL developed a unique and versatile AI-platform named innov’SAR that allows predicting multiple types of innovation in Life Sciences and biotechnology. PEACCEL provides solutions to make risky and investment intensive drug and enzyme development more efficient. Innovation cycles become with innov’SAR faster, more calculatable, and yield better results at lower costs compared to conventional methods.

Recent News

  • The CEO of PEACCEL, Laurent Contaut, has been awarded “CEO of the Year 2021” by AI Global Media Ltd
  • PEACCEL mentioned as a AI start-up to watch by NVIDIA
  • PEACCEL listed in the Global AI-based Drug Discovery Market Report 2021:  Market report by Cision (NYSE: CISN).

Search

Credits

  • Legal notice
  • Sitemap

© 2020 PEACCEL. All Rights Reserved.